Ain Holdings Inc. (TYO:9627)
Japan
· Delayed Price · Currency is JPY 4,945.00
-172.00 (-3.36%)
Apr 2, 2025, 3:30 PM JST
Ain Holdings Revenue
Ain Holdings had revenue of 121.97B JPY in the quarter ending January 31, 2025, with 18.84% growth. This brings the company's revenue in the last twelve months to 440.30B, up 12.55% year-over-year. In the fiscal year ending April 30, 2024, Ain Holdings had annual revenue of 399.82B with 11.45% growth.
Revenue (ttm)
440.30B
Revenue Growth
+12.55%
P/S Ratio
0.41
Revenue / Employee
38.37M
Employees
11,474
Market Cap
179.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2024 | 399.82B | 41.08B | 11.45% |
| Apr 30, 2023 | 358.74B | 42.50B | 13.44% |
| Apr 30, 2022 | 316.25B | 18.94B | 6.37% |
| Apr 30, 2021 | 297.31B | 4.69B | 1.60% |
| Apr 30, 2020 | 292.62B | 17.02B | 6.18% |
| Apr 30, 2019 | Pro | Pro | Pro |
| Apr 30, 2018 | Pro | Pro | Pro |
| Apr 30, 2017 | Pro | Pro | Pro |
| Apr 30, 2016 | Pro | Pro | Pro |
| Apr 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,170.61B |
| Daiichi Sankyo Company | 1,795.99B |
| Takeda Pharmaceutical Company | 4,579.02B |
| HOYA Corporation | 837.44B |
| Otsuka Holdings | 2,329.86B |
| Terumo | 1,011.15B |
| Astellas Pharma | 1,867.63B |
| Olympus | 993.33B |